Injectable extended-release naltrexone for opioid dependence Reply

被引：1
|
作者：
Wolfe, Daniel [1 ]
Carrieri, M. P. [2 ,3 ,4 ]
Dasgupta, Nabarun [5 ]
Bruce, Douglas [6 ]
Wodak, Alex [7 ]
机构：
[1] Open Soc Fdn, Int Harm Reduct Dev Program, New York, NY 10019 USA
[2] INSERM, U912, SE4S, F-13258 Marseille, France
[3] Univ Aix Marseille, IRD, Marseille, France
[4] ORS PACA, Marseille, France
[5] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA
[6] Yale Univ, AIDS Programme, New Haven, CT USA
[7] St Vincents Hosp, Alcohol & Drug Serv, Darlinghurst, NSW 2010, Australia
来源：
LANCET | 2011年 / 378卷 / 9792期
关键词：
PHARMACOTHERAPIES;
D O I：
10.1016/S0140-6736(11)61333-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：666 / 666
页数：1
相关论文
共 50 条
  • [1] Injectable extended-release naltrexone for opioid dependence
    Throckmorton, Douglas C.
    Temple, Robert
    Rappaport, Bob A.
    Roca, Rigoberto
    Winchell, Celia J.
    LANCET, 2011, 378 (9792): : 665 - 666
  • [2] Pharmacotherapy of opioid dependence with the extended-release injectable naltrexone
    Wang, A. L.
    Elman, I.
    Lowen, S.
    Blady, S. J.
    Lynch, K. G.
    O'Brian, C. P.
    Langleben, D. D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S696 - S696
  • [3] Efficacy and safety of extended-release injectable naltrexone for the treatment of opioid dependence
    Krupitsky, E.
    Illeperuma, A.
    Gastfriend, D.
    Silverman, B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S576 - S576
  • [4] Injectable extended-release naltrexone for the prevention of relapse to opioid dependence following opioid detoxification
    Krupitsky, Evgeny
    NEUROPSYCHIATRY, 2012, 2 (04) : 355 - 362
  • [5] Injectable Extended-Release Naltrexone Effective for Opioid Use Disorder
    Slawson, David C.
    AMERICAN FAMILY PHYSICIAN, 2018, 97 (12) : 819 - 819
  • [6] Treating Opioid Dependence With Injectable Extended-Release Naltrexone (XR-NTX) Who Will Respond?
    Nunes, Edward V.
    Krupitsky, Evgeny
    Ling, Walter
    Zummo, Jacqueline
    Memisoglu, Asli
    Silverman, Bernard L.
    Gastfriend, David R.
    JOURNAL OF ADDICTION MEDICINE, 2015, 9 (03) : 238 - 243
  • [7] A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependence
    Bisaga, Adam
    Sullivan, Maria A.
    Glass, Andrew
    Mishlen, Kaitlyn
    Carpenter, Kenneth M.
    Mariani, John J.
    Levin, Frances R.
    Nunes, Edward V.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2014, 46 (05) : 546 - 552
  • [8] Efficacy and Safety of Injectable Extended-Release Naltrexone (XR-NTX) for the Treatment of Opioid Dependence
    Gastfriend, David R.
    Krupitsky, Evgeny
    Nunes, Edward V.
    Ling, Walter
    Illeperuma, Ari
    Silverman, Bernard L.
    AMERICAN JOURNAL ON ADDICTIONS, 2011, 20 (04): : 389 - 389
  • [9] Extended-release injectable naltrexone for opioid use disorder: a systematic review
    Jarvis, Brantley P.
    Holtyn, August F.
    Subramaniam, Shrinidhi
    Tompkins, D. Andrew
    Oga, Emmanuel A.
    Bigelow, George E.
    Silverman, Kenneth
    ADDICTION, 2018, 113 (07) : 1188 - 1209
  • [10] EOSINOPHILIC PNEUMONIA AND EXTENDED-RELEASE INJECTABLE NALTREXONE
    Mears, Caroline
    McCoy, Kari
    Qiao, Xian
    CHEST, 2021, 160 (04) : 1679A - 1679A
12345